A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.052578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Tao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Généthon, 91000 Evry France. Hauptthemen laut MEDLINE: Exons, Dystrophin, Muscular Dystrophy, Duchenne, Sequence Deletion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Medicale (FRM), Association Française contre les Myopathies (AFM), Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Pathogenic variants in the dystrophin (DMD) gene cause muscle-wasting disorders ranging from the milder Becker muscular dystrophy (BMD) to the more severe Duchenne muscular dystrophy (DMD). Exon 45 deletion is the most-frequent single-exon deletion in patients diagnosed with DMD. Here, we generated a novel rat model with an exon 45 deletion using CRISPR/Cas9. The DmdΔ45 rat recapitulate key features of DMD, including progressive skeletal muscle degeneration, impaired muscle and cardiac function, and cognitive deficits. Transcriptomics analyses revealed gene expression patterns consistent with dystrophin deficiency. In skeletal muscle, we observed a transition from early stress responses and regeneration to chronic inflammation, fibrosis and metabolic dysfunction. Cardiac profiles similarly progressed from early inflammatory responses to fibrotic remodelling and metabolic impairment. Notably, DmdΔ45 rats displayed a milder phenotype than other DMD rat models. This attenuation is likely due to spontaneous exon skipping, particularly of exon 44, which partially restores the reading frame and increases revertant dystrophin-positive fibres with age. Downregulation of spliceosome-related genes suggests a potential mechanism for this exon skipping. Overall, this model provides valuable insights into phenotypic variability and therapeutic exon-skipping strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Généthon, 91000 Evry France.
- Université Paris-Saclay, Univ. Evry, INSERM, Généthon, INTEGRARE Research Unit UMR_S951, 91000, Evry-Courcouronnes, France.
ORCID-Profile: Abbass Jaber, Isabelle Richard
Förderung
- Fondation pour la Recherche Medicale (FRM)
- Association Française contre les Myopathies (AFM)
- Fondation pour la Recherche Médicale
- Institut National de la Santé Et de la Recherche Médicale (INSERM)
Zitieren
APA
Wang, T., Daoud, C., Dubois, A., Corre, G., Bellec, J., Bovolenta, M., Philidet, L., Dorval, A., Bourg, N., Roudaut, C., Albini, S., Warthi, G., Jaber, A., & Richard, I. (2026). A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052578
Vancouver
Wang T, Daoud C, Dubois A, Corre G, Bellec J, Bovolenta M, et al. A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052578
BibTeX
@article{Wang2026,
author = {Wang, Tao and Daoud, Cynthia and Dubois, Auriane and Corre, Guillaume and Bellec, Jessica and Bovolenta, Matteo and Philidet, Louise and Dorval, Alan and Bourg, Nathalie and Roudaut, Carinne and Albini, Sonia and Warthi, Ganesh and Jaber, Abbass and Richard, Isabelle},
title = {A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052578}
}
EUVIMED